|
|
Company: |
Indiana University Vector Production Facility |
|
Headquarters: |
975 West Walnut St.
IB-557C
Indianapolis,
IN
46202 |
|
Web Site Address: |
www.iuvpf.org |
|
Number of Employees: |
13 |
|
Company Description: |
|
Thank you for your interest in the Indiana University Vector Production Facility (IU VPF). The IU VPF is located on the Indiana University Medical Center Campus, part of Indiana University-Purdue University at Indianapolis. The IU VPF is a laboratory within the Indiana University School of Medicine and the Department of Medical and Molecular Genetics and is dedicated to the development, production and testing of gene therapy technology. The IU VPF is directed by Dr. Kenneth Cornetta, the Chairman of Medical and Molecular Genetics and the Vice President of the American Society for Gene Therapy. The production facility contains two production suites which are dedicated to specific vector systems. One suite is used to produce retroviral vectors and the other is used to produce lentiviral vectors. In addition to the production services, the IU VPF offers a wide variety of routine and specialized assays important in safety testing and certifying both clinical and non-clinical grade vectors. Vector titering is available using cell culture, while FACS, PCR and quantitative PCR assays are available to accommodate a wide variety of vector constructs. Quantitative PCR is also available to measure transduction efficiency in-vitro and in-vivo. Click here for a complete description of services. To date, the IU VPF has certified over 30 vectors for clinical trials throughout the United States and abroad. |
|
Services provided by category: |
|
Analytical Testing, Assay Development, Biologics Manufacturing, Clinical Monitoring, Contract Manufacturing, Delivery, DNA/RNA Prep, DNA Sequencing, Drug Development Services, Full Scale Manufacturing, GMPs, In Vitro Testing, Manufacturing, Molecular Biology, Phase I Clinical Trials, Phase II Clinical Trials, Preclinical, Retroviral Vectors, Safety, Scale-Up, Storage |
|
|
|
|
